X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (44920) 44920
Publication (5148) 5148
Book Review (1632) 1632
Book Chapter (126) 126
Conference Proceeding (86) 86
Dissertation (30) 30
Reference (5) 5
Magazine Article (3) 3
Book / eBook (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (42640) 42640
animals (27301) 27301
humans (24006) 24006
mitogen-activated protein kinases - metabolism (13244) 13244
mice (13137) 13137
phosphorylation (12385) 12385
rats (10426) 10426
cells, cultured (9776) 9776
male (9499) 9499
p38 mitogen-activated protein kinases - metabolism (9342) 9342
signal transduction - drug effects (9107) 9107
biochemistry & molecular biology (9068) 9068
signal transduction (8815) 8815
apoptosis (8696) 8696
cell biology (8188) 8188
mitogen-activated protein kinase 1 - metabolism (7399) 7399
expression (6927) 6927
enzyme inhibitors - pharmacology (6872) 6872
apoptosis - drug effects (6819) 6819
activation (6799) 6799
cell line (6434) 6434
phosphorylation - drug effects (6361) 6361
cell line, tumor (6321) 6321
female (6018) 6018
mitogen-activated protein kinase 3 - metabolism (5861) 5861
enzyme activation - drug effects (5501) 5501
map kinase (5053) 5053
oncology (5052) 5052
jnk mitogen-activated protein kinases - metabolism (4914) 4914
map kinase signaling system - drug effects (4812) 4812
kinases (4710) 4710
dose-response relationship, drug (4657) 4657
pharmacology & pharmacy (4647) 4647
blotting, western (4597) 4597
proteins (4478) 4478
activated protein-kinase (4434) 4434
nf-kappa b - metabolism (4169) 4169
enzyme activation (4078) 4078
oxidative stress (4028) 4028
rats, sprague-dawley (4023) 4023
cell proliferation - drug effects (3959) 3959
gene-expression (3724) 3724
cells (3654) 3654
protein kinases (3610) 3610
neurosciences (3590) 3590
inflammation (3556) 3556
nf-kappa-b (3420) 3420
mitogen-activated protein kinases - antagonists & inhibitors (3419) 3419
cell survival - drug effects (3407) 3407
cancer (3348) 3348
time factors (3228) 3228
gene expression (3196) 3196
inhibition (3125) 3125
signal transduction - physiology (3089) 3089
in-vitro (3082) 3082
imidazoles - pharmacology (3008) 3008
pyridines - pharmacology (3003) 3003
research (3002) 3002
p38 mitogen-activated protein kinases (2947) 2947
flavonoids - pharmacology (2935) 2935
protein kinase inhibitors - pharmacology (2908) 2908
immunology (2894) 2894
reactive oxygen species - metabolism (2893) 2893
rna, messenger - metabolism (2863) 2863
p38 mitogen-activated protein kinases - antagonists & inhibitors (2846) 2846
proto-oncogene proteins c-akt - metabolism (2834) 2834
article (2790) 2790
mitogen-activated protein kinase kinases - metabolism (2789) 2789
phosphatidylinositol 3-kinases - metabolism (2751) 2751
analysis (2740) 2740
extracellular signal-regulated map kinases - metabolism (2729) 2729
pathway (2728) 2728
mitogen-activated protein kinase (2697) 2697
mitogen-activated protein kinases (2633) 2633
physiology (2615) 2615
mice, inbred c57bl (2548) 2548
transfection (2523) 2523
mitogen-activated protein kinase 3 (2482) 2482
proliferation (2453) 2453
protein-kinase (2388) 2388
abridged index medicus (2357) 2357
gene expression regulation - drug effects (2338) 2338
physiological aspects (2308) 2308
signal-transduction (2306) 2306
mapk (2286) 2286
disease models, animal (2232) 2232
research article (2172) 2172
in-vivo (2143) 2143
rodents (2092) 2092
jnk mitogen-activated protein kinases (2088) 2088
tumor cells, cultured (2072) 2072
endocrinology & metabolism (2056) 2056
kinase (2050) 2050
growth (2025) 2025
mitogens (1986) 1986
antineoplastic agents - pharmacology (1982) 1982
reverse transcriptase polymerase chain reaction (1980) 1980
map kinase signaling system - physiology (1962) 1962
protein-serine-threonine kinases - metabolism (1961) 1961
up-regulation (1955) 1955
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (44423) 44423
Chinese (430) 430
Japanese (40) 40
Russian (33) 33
French (12) 12
German (7) 7
Hungarian (5) 5
Korean (4) 4
Spanish (4) 4
Ukrainian (4) 4
Polish (2) 2
Swedish (2) 2
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 2016, Volume 311, Issue 4, pp. H871 - H880
We previously reported that endoplasmic reticulum (ER) stress is induced in the subfornical organ (SFO) and the hypothalamic paraventricular nucleus (PVN) of... 
Heart failure | Brain | Sympathetic activity | Hypothalamic paraventricular nucleus | Mitogen-activated protein kinase | Subfornical organ | Endoplasmic reticulum stress | heart failure | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | PHYSIOLOGY | INDUCED PHOSPHORYLATION | MYOCARDIAL-INFARCTION | ER STRESS | subfornical organ | KINASE | RATS | sympathetic activity | KAPPA-B | brain | endoplasmic reticulum stress | hypothalamic paraventricular nucleus | mitogen-activated protein kinase | UNFOLDED PROTEIN RESPONSE | PERIPHERAL VASCULAR DISEASE | UP-REGULATION | Cholagogues and Choleretics - pharmacology | Tumor Necrosis Factor-alpha - genetics | Heart Failure - physiopathology | Male | NF-KappaB Inhibitor alpha - genetics | Peptidyl-Dipeptidase A - drug effects | Interleukin-1beta - genetics | Sympathetic Nervous System - physiopathology | RNA, Messenger - metabolism | Activating Transcription Factor 6 - genetics | Subfornical Organ - drug effects | Brain - metabolism | Heat-Shock Proteins - genetics | Inflammation - metabolism | Receptor, Angiotensin, Type 1 - genetics | Cyclooxygenase 2 - genetics | p38 Mitogen-Activated Protein Kinases - metabolism | Real-Time Polymerase Chain Reaction | Echocardiography | Signal Transduction | Rats | Cyclooxygenase 2 - drug effects | Heart Failure - metabolism | Rats, Sprague-Dawley | Blotting, Western | Brain - drug effects | Tumor Necrosis Factor-alpha - drug effects | Mitogen-Activated Protein Kinase 3 - metabolism | Endoplasmic Reticulum Stress | Paraventricular Hypothalamic Nucleus - metabolism | Infusions, Intraventricular | Mitogen-Activated Protein Kinases - drug effects | Mitogen-Activated Protein Kinase 1 - metabolism | Interleukin-1beta - drug effects | Sympathetic Nervous System - drug effects | Mitogen-Activated Protein Kinase 1 - drug effects | X-Box Binding Protein 1 - drug effects | Sympathetic Nervous System - metabolism | Transcription Factor RelA - genetics | Activating Transcription Factor 6 - drug effects | Mitogen-Activated Protein Kinase 3 - drug effects | Taurochenodeoxycholic Acid - pharmacology | Peptidyl-Dipeptidase A - genetics | Renin-Angiotensin System | Receptor, Angiotensin, Type 1 - drug effects | RNA, Messenger - drug effects | Subfornical Organ - metabolism | Heat-Shock Proteins - drug effects | Activating Transcription Factor 4 - genetics | Activating Transcription Factor 4 - drug effects | NF-KappaB Inhibitor alpha - drug effects | Paraventricular Hypothalamic Nucleus - drug effects | p38 Mitogen-Activated Protein Kinases - drug effects | Animals | Transcription Factor RelA - drug effects | X-Box Binding Protein 1 - genetics | Mitogen-Activated Protein Kinases - metabolism | Physiological aspects | Cellular signal transduction | Endoplasmic reticulum | Health aspects | Mitogen-activated protein kinases | Signal transduction | Inflammation | Kinases | Index Medicus | Cardiovascular Neurohormonal Regulation
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 03/2004, Volume 24, Issue 13, pp. 3370 - 3378
The mechanisms of action of human synthetic and naturally secreted cell-derived amyloid beta-peptide (Abeta)(1-42) on the induction of long-term potentiation... 
Metabotropic glutamate receptors | Cdk5 | JNK | LTP | Amyloid β-protein | Alzheimer's disease | p38 MAPK | Hippocampus | NEURONAL APOPTOSIS | hippocampus | ALZHEIMERS-DISEASE | MAP KINASE | metabotropic glutamate receptors | amyloid beta-protein | SYNAPTIC PLASTICITY | FREQUENCY STIMULATION | AREA CA1 | NEUROSCIENCES | IN-VITRO | PATHWAY | MICE | PRECURSOR PROTEIN | Receptors, Metabotropic Glutamate - drug effects | Cyclin-Dependent Kinases - metabolism | Amyloid beta-Peptides - pharmacology | Humans | Amyloid beta-Peptides - secretion | Peptide Fragments - pharmacology | Receptors, Metabotropic Glutamate - metabolism | Hippocampus - drug effects | Ovary - cytology | Excitatory Postsynaptic Potentials - drug effects | Cyclin-Dependent Kinases - drug effects | Dose-Response Relationship, Drug | Excitatory Postsynaptic Potentials - physiology | Long-Term Potentiation - drug effects | Amyloid beta-Peptides - genetics | JNK Mitogen-Activated Protein Kinases | Long-Term Potentiation - physiology | Receptor, Metabotropic Glutamate 5 | Female | Electric Stimulation - methods | Peptide Fragments - genetics | p38 Mitogen-Activated Protein Kinases | CHO Cells | Ovary - metabolism | Cricetinae | Enzyme Inhibitors - pharmacology | Peptide Fragments - secretion | Rats | Excitatory Amino Acid Antagonists - pharmacology | Cyclin-Dependent Kinase 5 | Animals | Ovary - secretion | Hippocampus - physiology | In Vitro Techniques | Mitogen-Activated Protein Kinases - drug effects | Mitogen-Activated Protein Kinases - metabolism | Index Medicus | Plasticity | Development | amyloid β-protein | Repair
Journal Article
Hepatology, ISSN 0270-9139, 04/2014, Volume 59, Issue 4, pp. 1543 - 1554
This study examines the role of protein kinase C (PKC) and AMP‐activated kinase (AMPK) in acetaminophen (APAP) hepatotoxicity. Treatment of primary mouse... 
OXIDATIVE STRESS | ACTIVATION | INHIBITION | RAT HEPATOCYTES | PHORBOL 12-MYRISTATE 13-ACETATE | AUTOPHAGY | GASTROENTEROLOGY & HEPATOLOGY | ISOENZYMES | INDUCED LIVER-INJURY | EXTENDED FAMILY | CELL-DEATH | Acetaminophen - adverse effects | Mitochondria, Liver - metabolism | Maleimides - pharmacology | Hepatocytes - pathology | Male | Hepatocytes - metabolism | Necrosis - pathology | AMP-Activated Protein Kinases - drug effects | Indoles - pharmacology | Chemical and Drug Induced Liver Injury - pathology | Hepatocytes - drug effects | Disease Models, Animal | JNK Mitogen-Activated Protein Kinases - drug effects | JNK Mitogen-Activated Protein Kinases - antagonists & inhibitors | Protein Kinase C - physiology | AMP-Activated Protein Kinases - antagonists & inhibitors | Mice, Inbred C57BL | Protein Kinase C - drug effects | Cells, Cultured | Necrosis - metabolism | Protein Kinase C - antagonists & inhibitors | Chemical and Drug Induced Liver Injury - physiopathology | Mitochondria, Liver - drug effects | AMP-Activated Protein Kinases - physiology | Animals | Chemical and Drug Induced Liver Injury - metabolism | JNK Mitogen-Activated Protein Kinases - physiology | Signal Transduction - physiology | Mice | Protein Kinase Inhibitors - pharmacology | In Vitro Techniques | Cytotoxicity | Mitochondria | Kinases | Autophagy | Liver | Hepatology | Index Medicus
Journal Article
Oncogene, ISSN 0950-9232, 01/2001, Volume 20, Issue 2, pp. 147 - 155
The anti-cancer agent paclitaxel (Taxol) stabilizes microtubules leading to G2/M cell cycle arrest and apoptotic cell death. In order to analyse the molecular... 
MAP kinase | Her-2 | Taxol | Cell cycle | Apoptosis | p53 | CARCINOMA-CELLS | ACTIVATED PROTEIN-KINASE | cell cycle | PHOSPHORYLATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | apoptosis | PHOSPHOINOSITIDE 3-KINASE | HEREGULIN | CELL BIOLOGY | BREAST-CANCER CELLS | BCL-2 | ONCOLOGY | GROWTH ARREST | GENETICS & HEREDITY | taxol | DIFFERENTIATION | HUMAN TUMOR-CELLS | Cyclin-Dependent Kinases - metabolism | Paclitaxel - pharmacology | Receptor, ErbB-2 - genetics | Apoptosis - drug effects | Humans | Receptor, ErbB-2 - metabolism | G2 Phase - drug effects | Tumor Suppressor Protein p53 - genetics | Breast Neoplasms - metabolism | Cyclin-Dependent Kinases - drug effects | Cyclin-Dependent Kinase 2 | Cyclins - metabolism | Cyclins - drug effects | Retinoblastoma Protein - drug effects | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Female | Flavonoids - pharmacology | Tumor Cells, Cultured | Carcinoma - pathology | Receptor, ErbB-2 - drug effects | p38 Mitogen-Activated Protein Kinases | Protein-Serine-Threonine Kinases - metabolism | Carcinoma - drug therapy | CDC2-CDC28 Kinases | Cyclin-Dependent Kinase Inhibitor p21 | Retinoblastoma Protein - metabolism | Enzyme Inhibitors - pharmacology | Protein-Serine-Threonine Kinases - genetics | Tumor Suppressor Protein p53 - metabolism | Rats | Imidazoles - pharmacology | Breast Neoplasms - drug therapy | Tumor Suppressor Protein p53 - drug effects | Animals | MAP Kinase Signaling System - drug effects | Mitosis - drug effects | Mitogen-Activated Protein Kinases - antagonists & inhibitors | Breast Neoplasms - pathology | Protein-Serine-Threonine Kinases - drug effects | Pyridines - pharmacology | Carcinoma - metabolism | Antineoplastic Agents, Phytogenic - pharmacology | Mitogen-Activated Protein Kinases - drug effects | MAP Kinase Kinase Kinase 1 | Mitogen-Activated Protein Kinases - metabolism | Index Medicus
Journal Article
Molecular and Cellular Biology, ISSN 0270-7306, 01/2010, Volume 30, Issue 2, pp. 470 - 480
Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley... 
FORKHEAD TRANSCRIPTION FACTOR | OXIDATIVE STRESS | ATROPHY | JNK | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENE-EXPRESSION | P38 MAPK | EXTENDS LIFE-SPAN | SURVIVAL SIGNALS | AKT | UBIQUITIN LIGASES | CELL BIOLOGY | Humans | Muscle Cells - drug effects | Oxidative Stress - physiology | SKP Cullin F-Box Protein Ligases - drug effects | Phosphatidylinositol 3-Kinases - metabolism | Forkhead Transcription Factors - drug effects | Muscle Fibers, Skeletal - drug effects | Muscle Fibers, Skeletal - metabolism | Mitogen-Activated Protein Kinase Kinases - metabolism | Cell Nucleus - metabolism | Isoquinolines - pharmacology | MAP Kinase Kinase 4 - metabolism | Transfection | Forkhead Transcription Factors - metabolism | Phosphatidylinositol 3-Kinases - drug effects | Muscle Proteins - metabolism | p38 Mitogen-Activated Protein Kinases - metabolism | MAP Kinase Kinase 4 - drug effects | Chromones - pharmacology | Proto-Oncogene Proteins c-akt - metabolism | Cell Line | Muscular Atrophy - metabolism | Receptors, Cytoplasmic and Nuclear - drug effects | Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors | Muscle Cells - metabolism | Morpholines - pharmacology | Thiophenes - pharmacology | Muscle Proteins - drug effects | Muscular Atrophy - genetics | MAP Kinase Kinase 3 - drug effects | SKP Cullin F-Box Protein Ligases - metabolism | Sulfonamides - pharmacology | Anthracenes - pharmacology | MAP Kinase Kinase 3 - metabolism | p38 Mitogen-Activated Protein Kinases - drug effects | Animals | Karyopherins - metabolism | Signal Transduction - drug effects | Karyopherins - drug effects | Signal Transduction - physiology | Mice | Protein Kinase Inhibitors - pharmacology | Oxidative Stress - drug effects | Cell Nucleus - drug effects | Forkhead Box Protein O3 | Proto-Oncogene Proteins c-akt - drug effects | Receptors, Cytoplasmic and Nuclear - metabolism | Index Medicus
Journal Article
Genes and Development, ISSN 0890-9369, 08/2003, Volume 17, Issue 16, pp. 1969 - 1978
The p38 mitogen-activated protein kinase (MAPK) is activated in vitro by three different protein kinases: MKK3, MKK4, and MKK6. To examine the relative roles... 
MAP kinase | MKK3 | MKK4 | p38 | MKK6 | JNK | APOPTOSIS | ISOFORMS | SYNERGISTIC ACTIVATION | DEVELOPMENTAL BIOLOGY | CELL BIOLOGY | TARGETED DISRUPTION | DUAL PHOSPHORYLATION | EMBRYONIC STEM-CELLS | GENETICS & HEREDITY | P38-ALPHA | STRESS | EXPRESSION | SIGNAL-TRANSDUCTION PATHWAY | Tumor Necrosis Factor-alpha - metabolism | Mitogen-Activated Protein Kinase Kinases - genetics | Mitogen-Activated Protein Kinases - radiation effects | Male | Mitogen-Activated Protein Kinase Kinases - metabolism | Protein Isoforms - metabolism | p38 Mitogen-Activated Protein Kinases | Fibroblasts - metabolism | MAP Kinase Signaling System - radiation effects | Protein Isoforms - radiation effects | Cells, Cultured | Mitogen-Activated Protein Kinase Kinases - deficiency | Enzyme Activation - drug effects | Enzyme Activation - radiation effects | Ultraviolet Rays - adverse effects | Mice, Knockout | Gene Expression Regulation - drug effects | Tumor Necrosis Factor-alpha - pharmacology | Protein Isoforms - drug effects | Animals | MAP Kinase Signaling System - drug effects | Fibroblasts - radiation effects | Mice, Nude | Fibroblasts - drug effects | Gene Expression Regulation - radiation effects | Trans-Activators - metabolism | Fibroblasts - cytology | Mice | Mutation | Enzyme Activation - genetics | Mitogen-Activated Protein Kinases - drug effects | Mitogen-Activated Protein Kinases - metabolism | Physiological aspects | Genetic research | Genetic aspects | Mitogens | Protein kinases | Analysis | Index Medicus | Research Papers
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 11/2009, Volume 29, Issue 47, pp. 14741 - 14751
Alzheimer's disease (AD) is characterized by memory impairment, neurochemically by accumulation of beta-amyloid peptide (namely Abeta(1-42)) and... 
Memory Disorders - physiopathology | Presynaptic Terminals - pathology | Rats, Wistar | Peptide Fragments - toxicity | Nerve Degeneration - physiopathology | Male | Adenosine A2 Receptor Antagonists | Neuroprotective Agents - pharmacology | Nerve Degeneration - prevention & control | Caffeine - pharmacology | Receptor, Adenosine A2A - genetics | p38 Mitogen-Activated Protein Kinases - metabolism | Phosphorylation - drug effects | Cell Survival - physiology | Cell Survival - drug effects | Alzheimer Disease - physiopathology | Maze Learning - physiology | Presynaptic Terminals - drug effects | Amyloid beta-Peptides - toxicity | Mice, Inbred C57BL | Cells, Cultured | Alzheimer Disease - drug therapy | Phosphodiesterase Inhibitors - pharmacology | Rats | Pyrimidines - pharmacology | Receptor, Adenosine A2A - metabolism | Maze Learning - drug effects | Down-Regulation - genetics | Mice, Knockout | Triazoles - pharmacology | Amyloid beta-Peptides - antagonists & inhibitors | Synaptic Membranes - drug effects | p38 Mitogen-Activated Protein Kinases - drug effects | Animals | Memory Disorders - drug therapy | Peptide Fragments - antagonists & inhibitors | Alzheimer Disease - metabolism | Presynaptic Terminals - metabolism | Mice | Synaptic Membranes - metabolism | Nerve Degeneration - drug therapy | Memory Disorders - chemically induced | Index Medicus
Journal Article
Brain Research, ISSN 0006-8993, 2012, Volume 1494, pp. 1 - 8
Abstract Dexmedetomidine (Dex) has been demonstrated to provide neuroprotection against ischemia/reperfusion (I/R) injury. However, the exact mechanism of this... 
Neurology | MCAO | GSK-3β | ERK1/2 | PI3K | Dexmedetomidine | ACTIVATION | INCREASES | BRAIN-DAMAGE | MECHANISMS | FOREBRAIN ISCHEMIA | NEUROSCIENCES | NEUROPROTECTION | HIPPOCAMPUS | INSULIN | GSK-3 beta | STRESS | OCCLUSION | Protein Kinases - metabolism | Reperfusion Injury - etiology | Glycogen Synthase Kinase 3 - drug effects | Phosphatidylinositol 3-Kinase - drug effects | Cerebral Cortex - pathology | Glycogen Synthase Kinase 3 beta | Male | Mitogen-Activated Protein Kinase 1 - drug effects | CA1 Region, Hippocampal - drug effects | Brain Ischemia - enzymology | Mitogen-Activated Protein Kinase 3 - drug effects | CA1 Region, Hippocampal - pathology | Neuroprotective Agents - pharmacology | Infarction, Middle Cerebral Artery - complications | Dexmedetomidine - pharmacology | Cell Death - drug effects | Cerebral Cortex - drug effects | Phosphatidylinositol 3-Kinase - metabolism | Brain Ischemia - complications | Protein Kinases - drug effects | Reperfusion Injury - pathology | Reperfusion Injury - enzymology | Rats | Infarction, Middle Cerebral Artery - pathology | Glycogen Synthase Kinase 3 - metabolism | Rats, Sprague-Dawley | Animals | MAP Kinase Signaling System - drug effects | Reperfusion Injury - prevention & control | Mitogen-Activated Protein Kinase 3 - metabolism | Signal Transduction - drug effects | Brain Ischemia - drug therapy | Brain Ischemia - pathology | Signal Transduction - physiology | Infarction, Middle Cerebral Artery - enzymology | Mitogen-Activated Protein Kinase 1 - metabolism | Brain | Cerebral infarction | Edema | Neuroprotection | Phosphorylation | Cell survival | MEK inhibitors | Cortex | Extracellular signal-regulated kinase | Glycogen synthase kinase 3 | AKT protein | Data processing | Western blotting | 1-Phosphatidylinositol 3-kinase | Reperfusion | Ischemia | Cerebral blood flow | Wortmannin | Injuries | Index Medicus
Journal Article
Journal Article
American Journal of Physiology - Endocrinology and Metabolism, ISSN 0193-1849, 08/2016, Volume 311, Issue 2, pp. E530 - E541
To better understand the role of irisin in humans, we examined the effects of irisin in human primary adipocytes and fresh human subcutaneous white adipose... 
Irisin | Thermogenesis | Human white adipose tissue | Brown adipose tissue | Adipocytes browning | Osteogenesis | Adipogenesis | Immunohistochemistry | Thermogenesis - genetics | Up-Regulation | Phosphoproteins - drug effects | Extracellular Signal-Regulated MAP Kinases - drug effects | Adipocytes, Brown - metabolism | Adipogenesis - drug effects | Humans | Middle Aged | Extracellular Signal-Regulated MAP Kinases - metabolism | Phosphoproteins - metabolism | RNA, Messenger - metabolism | Young Adult | Adipocytes, White - drug effects | Exercise | Cell Respiration - drug effects | Adult | Female | p38 Mitogen-Activated Protein Kinases - metabolism | Adipogenesis - genetics | Real-Time Polymerase Chain Reaction | Osteogenesis - genetics | STAT3 Transcription Factor - metabolism | RNA, Messenger - drug effects | Uncoupling Protein 1 - drug effects | Fibronectins - pharmacology | Signal Transduction | Adipocytes, Brown - drug effects | Uncoupling Protein 1 - metabolism | Osteoblasts - drug effects | Osteogenesis - drug effects | Cells, Cultured | Mitochondria - metabolism | Mitochondria - drug effects | Subcutaneous Fat - cytology | Blotting, Western | Obesity - metabolism | p38 Mitogen-Activated Protein Kinases - drug effects | Cell Differentiation - drug effects | STAT3 Transcription Factor - drug effects | Adolescent | Aged | Thermogenesis - drug effects | Osteoblasts - metabolism | Adipocytes, White - metabolism | Fat cells | Growth | Physiological aspects | Bones | Physiological research | Research | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2017, Volume 12, Issue 5, pp. e0176699 - e0176699
Ultraviolet-B radiation (285-320 nm) elicits a number of cellular signaling elements. We investigated the preventive effect of linalool, a natural monoterpene,... 
IN-VITRO | REACTIVE OXYGEN | ASSAY | ACID | SIGNALING PATHWAY | MULTIDISCIPLINARY SCIENCES | DNA-DAMAGE | MECHANISMS | NF-KAPPA-B | PHOTOCARCINOGENESIS | MOUSE SKIN | DNA Damage - drug effects | Mitogen-Activated Protein Kinases - radiation effects | Apoptosis - drug effects | Apoptosis - radiation effects | Skin - metabolism | Humans | Antioxidants - pharmacology | Ultraviolet Rays - adverse effects | Monoterpenes - pharmacology | Signal Transduction - drug effects | Skin - radiation effects | Radiation-Protective Agents - pharmacology | Oxidative Stress - radiation effects | Oxidative Stress - drug effects | Signal Transduction - radiation effects | Mitogen-Activated Protein Kinases - drug effects | DNA Damage - radiation effects | Skin - drug effects | NF-kappa B - drug effects | Oxidative stress | Usage | Ultraviolet radiation | Research | Enantiomers | Analysis | Biotechnology | Phosphorylation | Melatonin | Toxicity | DNA damage | Guanosine | Homeostasis | Cytotoxicity | Mitochondrial DNA | Activation | Biochemistry | Compounds | Kinases | Damage prevention | Comet assay | Interleukin 6 | Proteins | Antioxidants | Rodents | Inhibition | Deoxyribonucleic acid--DNA | NF-κB protein | Bioassay | U.V. radiation | Bioassays | Extracellular signal-regulated kinase | MAP kinase | JNK protein | Inflammation | Tumor necrosis factor-α | Gelatinase B | Gelatinase A | Studies | Signaling | Damage detection | Lymphocytes B | Protein kinase | Linalool | Interleukin 10 | Irradiation | Skin | Cyclobutane | Radiation damage | Apoptosis | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 2010, Volume 246, Issue 1, pp. 8 - 17
Acetaminophen (APAP) overdose, which causes liver injury in animals and humans, activates c-jun N-terminal kinase (JNK). Although it was shown that the JNK... 
Mitochondria | Acetaminophen | JNK | Bax | Hepatotoxicity | Oxidant stress | SP600125 | BAX TRANSLOCATION | CELL INJURY | INDUCED LIVER-INJURY | TUMOR-NECROSIS-FACTOR | MITOCHONDRIAL PERMEABILITY TRANSITION | CULTURED MOUSE HEPATOCYTES | ONCOTIC NECROSIS | PROTECTIVE ROLE | IN-VIVO | PHARMACOLOGY & PHARMACY | TOXICOLOGY | NH2-TERMINAL KINASE | Liver - pathology | Phosphorylation | Liver - enzymology | Apoptosis - drug effects | Analgesics, Non-Narcotic - pharmacology | Nitric Oxide Synthase - drug effects | JNK Mitogen-Activated Protein Kinases - metabolism | Male | Alanine Transaminase - blood | Analgesics, Non-Narcotic - toxicity | Liver - drug effects | Acetaminophen - pharmacology | Enzyme Induction - drug effects | Nitric Oxide Synthase - biosynthesis | JNK Mitogen-Activated Protein Kinases - drug effects | JNK Mitogen-Activated Protein Kinases - antagonists & inhibitors | Subcellular Fractions - drug effects | Acetaminophen - toxicity | Mice, Inbred C57BL | bcl-2-Associated X Protein - metabolism | Enzyme Activation - drug effects | Reverse Transcriptase Polymerase Chain Reaction | Anthracenes - pharmacology | Blotting, Western | Mitochondria, Liver - drug effects | Peroxynitrous Acid - biosynthesis | Animals | JNK Mitogen-Activated Protein Kinases - physiology | Mice | Oxidative Stress - drug effects | Translocation, Genetic - genetics | Messenger RNA | Glutathione transferase | Nitric oxide | Mitochondrial DNA | Superoxide | Permeability | Index Medicus | OXYGEN COMPOUNDS | NITRIC OXIDE | DIGESTIVE SYSTEM | MITOCHONDRIA | 60 APPLIED LIFE SCIENCES | STRESSES | PHOSPHORUS-GROUP TRANSFERASES | GLANDS | OXIDIZERS | NITROGEN OXIDES | ENZYMES | DRUGS | VERTEBRATES | MICE | NITROGEN COMPOUNDS | RADIOPROTECTIVE SUBSTANCES | MAMMALS | ANIMALS | INJURIES | RODENTS | RESPONSE MODIFYING FACTORS | ORGANIC COMPOUNDS | TRANSFERASES | NITRITES | POLYPEPTIDES | CHALCOGENIDES | ORGANS | DISEASES | PEPTIDES | GLUTATHIONE | LIVER | PHOSPHOTRANSFERASES | OXIDES | PROTEINS | BODY | CELL CONSTITUENTS | Oxidant Stress
Journal Article